Literature DB >> 25646711

Excessive growth hormone expression in male GH transgenic mice adversely alters bone architecture and mechanical strength.

S V Lim1, M Marenzana, M Hopkinson, E O List, J J Kopchick, M Pereira, B Javaheri, J P Roux, P Chavassieux, M Korbonits, C Chenu.   

Abstract

Patients with acromegaly have a higher prevalence of vertebral fractures despite normal bone mineral density (BMD), suggesting that GH overexpression has adverse effects on skeletal architecture and strength. We used giant bovine GH (bGH) transgenic mice to analyze the effects of high serum GH levels on BMD, architecture, and mechanical strength. Five-month-old hemizygous male bGH mice were compared with age- and sex-matched nontransgenic littermates controls (NT; n=16/group). Bone architecture and BMD were analyzed in tibia and lumbar vertebrae using microcomputed tomography. Femora were tested to failure using three-point bending and bone cellular activity determined by bone histomorphometry. bGH transgenic mice displayed significant increases in body weight and bone lengths. bGH tibia showed decreases in trabecular bone volume fraction, thickness, and number compared with NT ones, whereas trabecular pattern factor and structure model index were significantly increased, indicating deterioration in bone structure. Although cortical tissue perimeter was increased in transgenic mice, cortical thickness was reduced. bGH mice showed similar trabecular BMD but reduced trabecular thickness in lumbar vertebra relative to controls. Cortical BMD and thickness were significantly reduced in bGH lumbar vertebra. Mechanical testing of femora confirmed that bGH femora have decreased intrinsic mechanical properties compared with NT ones. Bone turnover is increased in favor of bone resorption in bGH tibia and vertebra compared with controls, and serum PTH levels is also enhanced in bGH mice. These data collectively suggest that high serum GH levels negatively affect bone architecture and quality at multiple skeletal sites.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25646711      PMCID: PMC4399323          DOI: 10.1210/en.2014-1572

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  61 in total

1.  Bone mineral density and turnover in patients with acromegaly in relation to sex, disease activity, and gonadal function.

Authors:  Marek Bolanowski; Jacek Daroszewski; Marek Medraś; Beata Zadrozna-Sliwka
Journal:  J Bone Miner Metab       Date:  2006       Impact factor: 2.626

2.  Bone embedding in pure methyl methacrylate at low temperature preserves enzyme activities.

Authors:  D Chappard; S Palle; C Alexandre; L Vico; G Riffat
Journal:  Acta Histochem       Date:  1987       Impact factor: 2.479

3.  Local expression of human growth hormone in bone results in impaired mechanical integrity in the skeletal tissue of transgenic mice.

Authors:  K F Tseng; J F Bonadio; T A Stewart; A R Baker; S A Goldstein
Journal:  J Orthop Res       Date:  1996-07       Impact factor: 3.494

Review 4.  Transgenic models of growth hormone action.

Authors:  J J Kopchick; L L Bellush; K T Coschigano
Journal:  Annu Rev Nutr       Date:  1999       Impact factor: 11.848

5.  Acromegaly has a negative influence on trabecular bone, but not on cortical bone, as assessed by high-resolution peripheral quantitative computed tomography.

Authors:  Miguel Madeira; Leonardo Vieira Neto; Francisco de Paula Paranhos Neto; Inayá Corrêa Barbosa Lima; Laura Maria Carvalho de Mendonça; Mônica Roberto Gadelha; Maria Lucia Fleiuss de Farias
Journal:  J Clin Endocrinol Metab       Date:  2013-03-12       Impact factor: 5.958

6.  Expression of metallothionein-human growth hormone fusion genes in transgenic mice results in disproportionate skeletal gigantism.

Authors:  E Wolf; K Rapp; G Brem
Journal:  Growth Dev Aging       Date:  1991

7.  Diabetic patients have an increased risk of vertebral fractures independent of BMD or diabetic complications.

Authors:  Masahiro Yamamoto; Toru Yamaguchi; Mika Yamauchi; Hiroshi Kaji; Toshitsugu Sugimoto
Journal:  J Bone Miner Res       Date:  2009-04       Impact factor: 6.741

8.  Age-related changes in body composition of bovine growth hormone transgenic mice.

Authors:  Amanda J Palmer; Min-Yu Chung; Edward O List; Jennifer Walker; Shigeru Okada; John J Kopchick; Darlene E Berryman
Journal:  Endocrinology       Date:  2008-10-23       Impact factor: 4.736

9.  Longitudinal in vivo effects of growth hormone overexpression on bone in transgenic mice.

Authors:  Felix Eckstein; Axel Weusten; Corina Schmidt; Ulrich Wehr; Rüdiger Wanke; Walter Rambeck; Eckhard Wolf; Subburaman Mohan
Journal:  J Bone Miner Res       Date:  2004-03-15       Impact factor: 6.741

10.  Progression of vertebral fractures despite long-term biochemical control of acromegaly: a prospective follow-up study.

Authors:  K M J A Claessen; H M Kroon; A M Pereira; N M Appelman-Dijkstra; M J Verstegen; M Kloppenburg; N A T Hamdy; N R Biermasz
Journal:  J Clin Endocrinol Metab       Date:  2013-09-30       Impact factor: 5.958

View more
  12 in total

Review 1.  Regulation of skeletal growth and mineral acquisition by the GH/IGF-1 axis: Lessons from mouse models.

Authors:  Shoshana Yakar; Olle Isaksson
Journal:  Growth Horm IGF Res       Date:  2015-09-28       Impact factor: 2.372

Review 2.  Acromegalic osteopathy.

Authors:  G Mazziotti; F Maffezzoni; S Frara; A Giustina
Journal:  Pituitary       Date:  2017-02       Impact factor: 4.107

Review 3.  Skeletal disorders associated with the growth hormone-insulin-like growth factor 1 axis.

Authors:  Gherardo Mazziotti; Andrea G Lania; Ernesto Canalis
Journal:  Nat Rev Endocrinol       Date:  2022-03-14       Impact factor: 43.330

4.  Bone histomorphometry in acromegaly patients with fragility vertebral fractures.

Authors:  L Dalle Carbonare; V Micheletti; E Cosaro; M T Valenti; M Mottes; G Francia; M V Davì
Journal:  Pituitary       Date:  2018-02       Impact factor: 4.107

5.  High-resolution-cone beam tomography analysis of bone microarchitecture in patients with acromegaly and radiological vertebral fractures.

Authors:  Filippo Maffezzoni; Michele Maddalo; Stefano Frara; Monica Mezzone; Ivan Zorza; Fabio Baruffaldi; Francesco Doglietto; Gherardo Mazziotti; Roberto Maroldi; Andrea Giustina
Journal:  Endocrine       Date:  2016-09-06       Impact factor: 3.633

Review 6.  Skeletal effects of growth hormone and insulin-like growth factor-I therapy.

Authors:  Richard C Lindsey; Subburaman Mohan
Journal:  Mol Cell Endocrinol       Date:  2015-09-25       Impact factor: 4.102

7.  Ablation of Hepatic Production of the Acid-Labile Subunit in Bovine-GH Transgenic Mice: Effects on Organ and Skeletal Growth.

Authors:  Zhongbo Liu; Tianzhen Han; Shannon Fishman; James Butler; Tracy Zimmermann; Frederic Tremblay; Carole Harbison; Nidhi Agrawal; John J Kopchick; Mitchell B Schaffler; Shoshana Yakar
Journal:  Endocrinology       Date:  2017-08-01       Impact factor: 4.736

8.  Human growth hormone proteoform pattern changes in pituitary adenomas: Potential biomarkers for 3P medical approaches.

Authors:  Biao Li; Xiaowei Wang; Chenguang Yang; Siqi Wen; Jiajia Li; Na Li; Ying Long; Yun Mu; Jianping Liu; Qin Liu; Xuejun Li; Dominic M Desiderio; Xianquan Zhan
Journal:  EPMA J       Date:  2021-03-03       Impact factor: 6.543

Review 9.  Update on vertebral fractures in pituitary diseases: from research to clinical practice.

Authors:  Flaminia Carrone; Salvatore Ariano; Sara Piccini; Davide Milani; Marco Mirani; Luca Balzarini; Andrea Gerardo Lania; Gherardo Mazziotti
Journal:  Hormones (Athens)       Date:  2021-02-19       Impact factor: 2.885

Review 10.  Effects of GH/IGF axis on bone and cartilage.

Authors:  Manisha Dixit; Sher Bahadur Poudel; Shoshana Yakar
Journal:  Mol Cell Endocrinol       Date:  2020-10-14       Impact factor: 4.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.